Rituximab-induced neutropenia in a patient with inflammatory myopathy and systemic sclerosis overlap disease

Rituximab (RTX) is a monoclonal chimeric antibody directed against the CD20 antigen of B lymphocytes. Late onset neutropenia (LON) is a recognised complication of rituximab usually occurring 4 weeks after the last dose and is reported in both haematological and rheumatological conditions. However, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Akram, Qasim, Roberts, Mark, Oddis, Chester, Herrick, Arianne, Chinoy, Hector
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847324/
https://www.ncbi.nlm.nih.gov/pubmed/27407275
http://dx.doi.org/10.5114/reum.2016.58760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847324/
https://www.ncbi.nlm.nih.gov/pubmed/27407275
http://dx.doi.org/10.5114/reum.2016.58760

Ejemplares similares